The management of PPROM depends on the balance between the risks for fetal and neonatal complications with immediate delivery versus the risks and benefits of conservative treatment. The neonatal risks are primarily gestational age related. Therefore, the initial steps include confirmation of membrane rupture in addition to assessment of estimated gestational age, duration of membrane rupture, exclusion of maternal infection or abruption and assessment of fetal well being. Several areas of controversies exist regarding the best medical approach or management of PROM remote from term. Expectant management and immediate delivery are potential options in these patients, and each has its own advantages and disadvantages. With appropriate care, the maternal risks of expectant management are generally expected to be minimal and a clear neonatal advantage exists by reducing risks of prematurity. Some of the issues in management are discussed below with available guidelines from the august bodies.
Usual Outcome of Expectancy:
o In absence of adjunctive treatments, for any patient with preterm PROM, birth within 1 week is the most likely outcome, o The earlier the PROM occurs, the greater is the latency period. o Spontaneous sealing of the membranes does occur occasionally (< 10% of all cases), mostly after PPROM that has occurred subsequent to amniocentesis; however, this is the exception rather than the rule
Diagnosis:
o The diagnosis is made by a history suggestive of spontaneous rupture of membranes followed by a sterile speculum examination demonstrating pooling of fluid in the posterior vaginal fornix o When the clinical history or physical examination is unclear, membrane rupture can be diagnosed unequivocally with USG guided transabdominal instillation of indigo carmine dye (1 mL in 9 mL of sterile normal saline), followed by observation for passage of blue fluid from the vagina.
o AmniSure, a rapid immunoassay, although accurate in the diagnosis, is still in the experimental stage. The sensitivity and specificity of Amnisure is 98.9% and 100% respectively.
General approaches of expectant management of preterm PROM: o There is no consensus on the frequency of optimal assessment, .
Use of tocolytics in PPROM:
o Available data do not support the routine use of either prophylactic or therapeutic tocolysis after PPROM.
o In absence of any evidence, a specific recommendation for or against tocolysis in cases of PPROM cannot be made.
Corticosteroids in PPROM:
o o A 48-hour course of intravenous Ampicillin and erythromycin followed by 5 days of amoxicillin and erythromycin is recommended during expectant management of preterm PROM to prolong pregnancy and to reduce infectious and gestational agedependent neonatal morbidity. (ACOG) o All women with PROM and a viable fetus, including those known to be carriers of GBS and those who give birth before carrier status can be delineated, should receive intrapartum chemoprophylaxis to prevent vertical transmission regardless of earlier treatments. (ACOG) o Revised guidelines from CDC recommend that women with PPROM who are not in labor should receive intravenous GBS coverage for at least the first 48 hours, until the GBS test results obtained on admission are available. However, GBS test results should not affect the duration of antibiotic therapy.
o If the patient completes the full course of antibiotic prophylaxis has no evidence of infection or labor, intrapartum GBS prophylaxis can be managed based on the results of the baseline GBS test at the time of PPROM, unless 5 weeks have passed. This is because a negative GBS test result is considered valid for 5 weeks
o Antibiotic regimens may consist of an initial parenteral phase followed by an oral phase, or may consist of only an oral phase.
o Ampicillin 2 g intravenously (IV) every 6 hours and erythromycin 250 mg IV every 6 hours for 48 hours followed by amoxicillin 250 mg orally every 8 hours and erythromycin 333 mg orally every 8 hours for 5 days o Erythromycin 250 mg orally every 6 hours for 10 days.
Time to deliver:
The conclusions were that there is insufficient evidence to guide clinical practice on the benefits and harms of immediate delivery compared with expectant management. (Cochrane 2010) Prior to 32 weeks o The evidence suggests expectant management with antibiotics and steroids in absence of any complication (infection, abruption, active labor or non-reassuring fetal heart).
o However, long term outcome of these preterm infants are a real concern.
PPROM ≥ 34 weeks o The procedures may be helpful in selected situations both for diagnosis (rupture of membranes, evidence of infection) and treatment. However, these uses are still in experimental stage.
PPROM with cervical cerclage in place:
o Because the available studies are small and nonrandomized, the optimal timing of cerclage removal is unclear.
o The result of a multicentric RCT of removal vs retention of cerclage in PPROM is expected to be published in 2012 and would likely to provide some answer based on evidence. 
